N@N

Market Maker Surveillance Report. BZH, THQI, ACHN, CLVS, LFVN, OMER, Losing Stocks With Lowest Price Friction For Monday, Nove

November 12, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4034 companies with "abnormal" market making, 2337 companies with positive Friction Factors and 3094 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Beazer Homes USA Inc (NYSE:BZH), THQ Inc (NASDAQ:THQI), Achillion Pharmaceuticals Inc (NASDAQ:ACHN), Clovis Oncology Inc (NASDAQ:CLVS), LifeVantage Corp (NASDAQ:LFVN), Omeros Corp (NASDAQ:OMER). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  BZH     $-2.870   -17.25%   2,587,552    32.70%    2,654,804    33.55%    -67,252      -234    
  THQI    $-0.200   -14.71%   203,591      35.51%    369,797      64.49%    -166,206     -8,310  
  ACHN    $-1.110   -12.32%   2,414,881    45.91%    2,656,215    50.49%    -241,334     -2,174  
  CLVS    $-8.990   -41.83%   1,586,513    48.10%    1,666,291    50.52%    -79,778      -89     
  LFVN    $-0.390   -13.49%   308,536      35.55%    555,973      64.07%    -247,437     -6,345  
  OMER    $-1.230   -14.96%   185,986      43.29%    242,825      56.52%    -56,839      -462    

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar losses (Change) and extremely low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows BZH with a dollar loss Monday of $-2.87000 and a Friction Factor of -234 shares. That means that it only took 234 more shares of selling than buying to move BZH lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Beazer Homes USA Inc (NYSE:BZH) - Beazer Homes USA, Inc. designs, builds, and sells single-family and multi-family homes in the United States. It offers homes for entry-level, move-up, or retirement-oriented buyers. The company sells its homes through commissioned new home sales counselors and independent brokers. Beazer Homes USA, Inc. was founded in 1985 and is headquartered in Atlanta, Georgia..

THQ Inc (NASDAQ:THQI) - THQ Inc. engages in developing, publishing, and distributing interactive entertainment software for various game systems. It offers its software for home video game consoles; handheld platforms; wireless devices, such as iPhone, iTouch and iPad; and personal computers (PC), including games played online. The company also develops and publishes titles for digital distribution, as well as offers PC titles through online download stores and services. In addition, it produces and markets action, fighting, racing, shooter, and strategy games primarily for avid or core gamers; games for the mass market and families; and online games. The company markets and distributes games directly to mass merchandisers, consumer electronic stores, discount warehouses, and other retail chain stores in the United States; and on a direct-to-retail basis, as well as through Internet and wireless devices internationally. THQ Inc. was founded in 1989 and is based in Agoura Hills, California..

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) - Achillion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for infectious diseases. The company focuses on the development of antivirals for the treatment of chronic hepatitis C; and the development of antibacterials for the treatment of resistant bacterial infections. Its drug candidate pipeline includes ACH-1625, a protease inhibitor, which is in phase 1/b clinical trials for the treatment of chronic hepatitis C infections; ACH-1095, a NS4A antagonist that is in late-stage preclinical studies for the treatment of chronic hepatitis C infections; and ACH-2684, a protease inhibitor, which is in late stage preclinical testing. The companys other product candidates comprise ACH-702, which is in preclinical stage for the treatment of serious bacterial infections; and Elvucitabine that is in phase II clinical trials for the treatment of HIV infection. The company has a collaboration arrangement with Gilead Sciences, Inc. to develop and commercialize compounds for the treatment of chronic hepatitis C, which inhibit viral replication through a mechanism of action. Achillion Pharmaceuticals, Inc. was founded in 1998 and is based in New Haven, Connecticut..

Clovis Oncology Inc (NASDAQ:CLVS) - CLASSIC VENTURES INC.

LifeVantage Corp (NASDAQ:LFVN) - Lifevantage Corporation, a dietary supplement company, manufactures, markets, distributes, and sells dietary supplements in the United States and internationally. The company primarily offers Protandim, a patented dietary supplement that increases the bodys natural antioxidant protection by inducing protective enzymes, including superoxide dismustase and catalase. It sells its products through network marketing, direct to consumer, and retail sales channels. Lifevantage Corporation was founded in 2003 and is headquartered in San Diego, California..

Omeros Corp (NASDAQ:OMER) - Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products focused on inflammation and disorders of the central nervous system. Its product candidates are derived from its proprietary PharmacoSurgery platform that is designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological, and other surgical and medical procedures. The companys lead PharmacoSurgery product candidate, OMS103HP, is in Phase III clinical program for evaluating OMS103HPs safety and ability to improve postoperative joint function and reduce pain following arthroscopic anterior cruciate ligament; and to reduce pain and improve postoperative joint function following arthroscopic meniscectomy surgery. Its PharmacoSurgery product candidates also include OMS302, which completed its Phase I/II clinical trial for use during ophthalmological procedures; and OMS201, which is in Phase I/II clinical trial for use during urological surgery. The company also engages in developing proprietary compositions that include peroxisome proliferator-activated receptor gamma (PPARγ) agonists for the treatment and prevention of addiction to substances of abuse. Its pipeline of preclinical product development programs include MASP-2 program for developing proprietary mannan-binding lectin-associated serine protease-2 antibody therapies to treat disorders caused by complement-activated inflammation; PDE10 program for developing proprietary compounds to treat schizophrenia and other psychotic disorders; PDE7 program for developing proprietary compounds to treat movement disorders; and GPCR program for the de-orphanization of orphan G protein-coupled receptors. Omeros Corporation was founded in 1994 and is based in Seattle, Washington..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net